TipRanks
Tonix Pharma (DE:TPM0)
FRANKFURT:TPM0
Germany Market
TPM0
Tonix Pharma
RESEARCH TOOLSreports

Tonix Pharma (TPM0) Income Statement

9 Followers

Tonix Pharma Income Statement

Last quarter (Q2 2026), Tonix Pharma's total revenue was $13.54M, an increase of 577.88% from the same quarter last year. In Q2, Tonix Pharma's net income was $-40.55M. See Tonix Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 13.11M$ 10.09M$ 7.77M$ 0.00$ 0.00
Gross Profit
$ 4.54M$ 2.33M$ 3.03M$ 0.00$ 0.00
Operating Expenses
$ 130.25M$ 139.03M$ 121.41M$ 112.09M$ 92.31M
Depreciation and Amortization
$ 1.93M$ 3.42M$ 4.29M$ 1.25M$ 50.00K
EBITDA
$ -122.01M$ -74.32M$ -112.37M$ -108.97M$ -92.24M
Operating Income
$ -125.70M$ -136.70M$ -118.38M$ -112.09M$ -92.31M
Other Income/Expenses
$ 1.68M$ 6.67M$ 1.72M$ 1.87M$ 25.00K
Pretax Income
$ -124.02M$ -130.04M$ -116.66M$ -110.22M$ -92.29M
Net Income
$ -124.02M$ -130.04M$ -116.66M$ -110.22M$ -92.29M
Per Share Metrics
Basic EPS
$ -14.57$ -176.60$ -6.37K$ -811.68$ -163.97K
Diluted EPS
$ -14.57$ -176.60$ -6.37K$ -811.68$ -163.97K
Weighted Average Shares Outstanding
 8.51M 2.26M 1.83M 3.07M 563.00
Weighted Average Shares Outstanding (Diluted)
 8.51M 2.26M 1.83M 3.07M 563.00
Currency in USD

Tonix Pharma Earnings and Revenue History